We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$780M
AUM Growth
+$181M
Cap. Flow
+$169M
Cap. Flow %
21.69%
Top 10 Hldgs %
29%
Holding
5,646
New
1,097
Increased
1,409
Reduced
2,025
Closed
1,047

Sector Composition

Rank Sector Weight
1 Financials 7.89%
2 Industrials 5.11%
3 Technology 4.56%
4 Energy 4.21%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAX
3176
DELISTED
Ambassadors Group Inc
EPAX
$6K ﹤0.01%
+1,412
New +$5.94K
HME
3177
DELISTED
HOME PROPERTIES, INC
HME
$6K ﹤0.01%
100
-4,480
-98% -$259K
NSLP
3178
DELISTED
NEW SOURCE ENERGY PARTNERS L P COM UNIT REPST LTD
NSLP
$6K ﹤0.01%
+242
New +$5.73K
HVB
3179
DELISTED
HUDSON VY HLDG CORP
HVB
$6K ﹤0.01%
295
-907
-75% -$16.9K
IGTE
3180
DELISTED
IGATE CORPORATION
IGTE
$6K ﹤0.01%
175
-1,683
-91% -$57.9K
ELX
3181
DELISTED
EMULEX CORP
ELX
$6K ﹤0.01%
781
+777
+19,425% +$5.71K
EVRY
3182
DELISTED
EVERYWARE GLOBAL INC COM STK (DE)
EVRY
$6K ﹤0.01%
1,409
-807
-36% -$5.5K
JRN
3183
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
$6K ﹤0.01%
718
-772
-52% -$6.86K
EGL
3184
DELISTED
Engility Holdings, Inc.
EGL
$6K ﹤0.01%
140
-1,144
-89% -$47K
SAPE
3185
DELISTED
SAPIENT CORP
SAPE
$6K ﹤0.01%
357
-243
-41% -$4.08K
TZV
3186
DELISTED
ISHARES TARGET DATE 2040 ETF
TZV
$6K ﹤0.01%
+128
New +$5.53K
MDCI
3187
DELISTED
MEDICAL ACTION INDS INC
MDCI
$6K ﹤0.01%
+814
New +$6.09K
PACR
3188
DELISTED
PACER INTL INC TENN
PACR
$6K ﹤0.01%
+623
New +$5.54K
AXTE
3189
DELISTED
ISHARES TR MSCI ACWI EX US TELECOM SVCS ETF
AXTE
$6K ﹤0.01%
+100
New +$6.14K
CELGZ
3190
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$6K ﹤0.01%
2,121
+143
+7% +$432
TDN
3191
DELISTED
DEUTSCHE X-TRACKERS 2030 TARGET DATE ETF
TDN
$6K ﹤0.01%
+200
New +$5.59K
REV
3192
DELISTED
Revlon, Inc.
REV
$6K ﹤0.01%
224
-408
-65% -$10K
UN
3193
DELISTED
Unilever NV New York Registry Shares
UN
$6K ﹤0.01%
147
-18,585
-99% -$723K
VVUS
3194
DELISTED
Vivus Inc
VVUS
$6K ﹤0.01%
100
-119
-54% -$8.46K
VRML
3195
DELISTED
Vermillion, Inc.
VRML
$6K ﹤0.01%
1,912
+487
+34% +$1.4K
CY
3196
DELISTED
Cypress Semiconductor
CY
$6K ﹤0.01%
600
-600
-50% -$6.07K
TSS
3197
DELISTED
Total System Services, Inc.
TSS
$6K ﹤0.01%
196
-2,934
-94% -$90.1K
JMBA
3198
DELISTED
Jamba, Inc.
JMBA
$6K ﹤0.01%
485
-145
-23% -$1.81K
WWAV
3199
DELISTED
The WhiteWave Foods Company
WWAV
$6K ﹤0.01%
+213
New +$5.63K
QUNR
3200
DELISTED
Qunar Cayman Islands Limited
QUNR
$6K ﹤0.01%
+203
New +$5.92K

Similar funds

Tower Research Capital (TRC)'s Q1 2014 Portfolio in Review

As of Q1 2014, Tower Research Capital (TRC) held 5,646 positions worth $780M, up 30% from $599M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $169M of net new capital in Q1 2014, opening 1,097 new positions and adding to 1,409 existing holdings. Its largest new stake was iShares US Real Estate ETF: 131,900 shares worth $8.93M.

By sector, the portfolio is most concentrated in Financials at 7.9% of assets, down from 8% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $40.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2014 buy was iShares US Real Estate ETF: 131,900 shares worth $8.93M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2014, an estimated $111M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $40.7M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2014, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $780M portfolio in Q1 2014.
  • Tower Research Capital (TRC) opened 1,097 new positions and closed 1,047 in Q1 2014.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $780M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2014, filed 2 May 2014.